                         SEQUENCE LISTING

<110>  Arizona Board of Regents on behalf of Arizona State 
       University
 
<120>  Temporal Traumatic Brain Injury Biomarkers and Methods of use 
       Thereof

<130>  11157.047PCT

<150>  US 62/865,009
<151>  2019-06-21

<150>  US 62/968,148
<151>  2020-01-30

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  1

Thr Ala Glu Arg Asp Ala Arg Thr Phe Gln Tyr 
1               5                   10      


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  2

Ser Leu Tyr Gly Ser Ser Arg His Thr Ala Pro Ile Ser Phe 
1               5                   10                  


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  3

Thr Asp Leu Ala Val Ala His Pro Val Arg Tyr 
1               5                   10      


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  4

Ala Ala Pro Ser Trp Asn Asn His Val Ser Tyr 
1               5                   10      


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  5

Arg Leu Val Arg Glu Ser Ser Gln Glu His Thr Leu Ser Ser 
1               5                   10                  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  6

Thr Asp Cys Gln Glu Thr Pro Tyr Glu Leu Lys Ser 
1               5                   10          


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  7

Thr Gly His Glu Gly Glu Asn Glu Met Ala Ser 
1               5                   10      


<210>  8
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  8

Gly Pro Leu Asp Gly Lys Glu Glu Glu Leu Arg Phe 
1               5                   10          


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  9

Gly Gly Asp Thr Phe Arg Asp Ala Ser Gln Ser Met His Phe 
1               5                   10                  


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = any amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = any amino acid or none

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa = any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = any amino acid or none

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  K= DLys

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Biotin

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Propargyl

<400>  10

Xaa Xaa Xaa Xaa Gly Ser Lys Ser Glu Lys Gly Gly 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X=any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X=any amino acid or none

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  K= DLys

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Biotin

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Propargyl

<400>  11

Glu Lys Xaa Xaa Gly Ser Lys Ser Glu Lys Gly Gly 
1               5                   10          


<210>  12
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X=any amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X=any amino acid or none

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  K=DLys

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Biotin

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Propargyl

<400>  12

Xaa Xaa Glu Gly Ser Lys Ser Glu Lys Gly Gly 
1               5                   10      


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  K=DLys

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Biotin

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  propargyl

<400>  13

Glu Lys Glu Gly Ser Lys Ser Glu Lys Gly Gly 
1               5                   10      


<210>  14
<211>  52
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  14
tcgtcggcag cgtcagatgt gtataagaga cagcagctgt tggagtctgg gg               52


<210>  15
<211>  53
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  15
gtctcgtggg ctcggagatg tgtataagag acaggagacg gtgaccaggg ttc              53


